Genetic variation and radiation quality impact cancer promoting cellular phenotypes in response to HZE exposure.

Life Sciences in Space Research
Deepa M SridharanJanice M Pluth

Abstract

There exists a wide degree of genetic variation within the normal human population which includes disease free individuals with heterozygote defects in major DNA repair genes. A lack of understanding of how this genetic variation impacts cellular phenotypes that inform cancer risk post heavy ion exposure poses a major limitation in developing personalized cancer risk assessment astronauts. We initiated a pilot study with Human Mammary Epithelial Cell strains (HMEC) derived from wild type, a p16 silenced derivative of wild type, and various genetic variants that were heterozygote for DNA repair genes; BRCA1, BRCA2 and ATM. Cells strains were exposed to different high and low LET radiation qualities to generate both simple and complex lesions and centrosome aberrations were examined as a surrogate marker of genomic instability and cancer susceptibility post different exposures. Our results indicate that centrosome aberration frequency is higher in the genetic variants under study. The aberration frequency increases with dose, complexity of the lesion generated by different radiation qualities and age of the individual. This increase in genomic instability correlates with elevated check-point activation post radiation exposure. Th...Continue Reading

References

Mar 22, 1996·Science·K FukasawaG F Vande Woude
Jul 14, 1998·Molecular Cell·K J PatelA R Venkitaraman
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·L C Hsu, R L White
Dec 30, 1998·International Journal of Radiation Oncology, Biology, Physics·J B WeissbergM Swift
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·K R LaceyT Stearns
Oct 3, 1999·Nature Genetics·M C HollanderA J Fornace
Nov 5, 1999·Molecular Cell·M E MoynahanM Jasin
Mar 21, 2000·American Journal of Human Genetics·A BroeksL J van 't Veer
Apr 8, 2000·Current Opinion in Genetics & Development·P Karran
Sep 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·S MatsuokaS J Elledge
Dec 2, 2000·Nature·B B Zhou, S J Elledge
Jun 18, 2002·FEBS Letters·P Meraldi, E A Nigg
Sep 6, 2002·Oncogene·Chu-Xia Deng
Sep 18, 2004·Science·Matthew J DanielsAshok R Venkitaraman
Nov 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Rui-Hong WangChu-Xia Deng
Feb 9, 2006·PLoS Biology·Kimberly M McDermottThea D Tlsty
Mar 2, 2006·Breast Cancer Research : BCR·Graham J MannUNKNOWN Kathleen Cuningham Consortium for Research in Familial Breast Cancer
Sep 26, 2006·Oncogene·M Ahmed, N Rahman
Oct 4, 2006·International Journal of Cancer. Journal International Du Cancer·Erich A Nigg
Apr 22, 2014·DNA Repair·Tomas AparicioJean Gautier
Jul 23, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·S A Godinho, D Pellman
Mar 31, 2015·Frontiers in Cell and Developmental Biology·Jonathan K LeeMark A LaBarge
Jun 27, 2015·Radiation Research·Deepa M SridharanJanice M Pluth
Mar 19, 2016·Advances in Experimental Medicine and Biology·Michael F WalshKenneth Offit
Aug 24, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kara N MaxwellMark E Robson

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.